Per Guldberg

6PUBLICATIONS
39CO-AUTHORS
Speciation and extinctionCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 06, 2024
Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulation.

Zita Gál, Stavroula Boukoura, Kezia Catharina Oxe

|May 09, 2024
Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.

Hege Marie Vedeld, Heidi Pharo, Anne Klara Sørbø

|Sep 11, 2023
Blood Leukocyte AHRR Methylation and Risk of Non-smoking-associated Cancer: A Case-cohort Study of Non-Hodgkin Lymphoma.

Christina Dahl, Ulla A Hvidtfeldt, Anne Tjønneland

|May 06, 2021
Loss of Ambra1 promotes melanoma growth and invasion.

Luca Di Leo, Valérie Bodemeyer, Francesca M Bosisio

|Mar 08, 2018
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.

Alexei F Kirkin, Karine N Dzhandzhugazyan, Per Guldberg

Pageof 1